Supriya Lifescience Limited IPO (Supriya Lifescience IPO) Detail

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.

In Fiscal 2021, the company’s products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.

Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure. The company’s manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.

Company Promoters:

Satish Waman Wagh is the company promoter.

Company Financials:

ParticularsFor the year/period ended (₹ in Millions)
Total Assets5,041.024,458.243,364.012,530.52
Total Revenue2,300.613,962.213,227.132,858.62
Profit After Tax659.591,238.28733.74394.24

Objects of the Issue:

  • Funding capital expenditure requirements of the company
  • Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company and
  • General corporate purposes

Supriya Lifescience IPO Details

IPO Opening DateDec 16, 2021
IPO Closing DateDec 20, 2021
Issue TypeBook Built Issue IPO
Face Value₹2 per equity share
IPO Price[.] to [.] per equity share
Market Lot
Min Order Quantity
Listing AtBSE, NSE
Issue Size[.] Eq Shares of ₹2
(aggregating up to ₹700.00 Cr)
Fresh Issue[.] Eq Shares of ₹2
(aggregating up to ₹200.00 Cr)
Offer for Sale[.] Eq Shares of ₹2
(aggregating up to ₹500.00 Cr)

Supriya Lifescience IPO Tentative Timetable

The Supriya Lifescience IPO open date is Dec 16, 2021, and the close date is Dec 20, 2021. The issue may list on Dec 28, 2021.

IPO Open DateDec 16, 2021
IPO Close DateDec 20, 2021
Basis of Allotment DateDec 23, 2021
Initiation of RefundsDec 24, 2021
Credit of Shares to Demat AccountDec 27, 2021
IPO Listing DateDec 28, 2021

Supriya Lifescience IPO Promoter Holding

Pre Issue Share Holding99.98%
Post Issue Share Holding

Company Contact Information

Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
Phone: +91-22-40332727

Supriya Lifescience IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Leave a Reply

Your email address will not be published. Required fields are marked *